Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2014, Vol. 8 Issue (4) : 464-470    https://doi.org/10.1007/s11684-014-0338-y
RESEARCH ARTICLE
Comparison of surgical indications for hysterectomy by age and approach in 4653 Chinese women
Jingjing Jiang,Ting Ding,Aiyue Luo,Yunping Lu,Ding Ma,Shixuan Wang()
Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
 Download: PDF(231 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Approximately one million hysterectomies are performed each year in China. However, national data regarding the indications and the surgical approaches for hysterectomy are lacking. The aim of this study was to examine the surgical indications for hysterectomy in different age groups and the relative merits of different surgical approaches for hysterectomy in Chinese women. Clinical data from 4653 cases of hysterectomy performed in Tongji Hospital from 2004 to 2009 were analysed. Hysterectomy was most commonly performed among women aged 40--49 years (2299; 49.4%). Overall, colporrhagia and abdominal pain were the two most common indications for hysterectomy. The most common indications by age groups were as follows: malignant ovarian tumour,<20 years; malignant uterine tumour, 20--29 and 30--39 years; uterine myoma, 40--49 and 50--59 years; and uterine prolapse, 60--69 and>70 years. The proportion of malignant aetiology also varied by age, being the highest in women aged<20 years (75.0%) and the lowest in those aged 40--49 years (19.9%). Approximately 35% women who had hysterectomies also had concomitant bilateral oophorectomy. The lowest rate of oophorectomy occurred in women aged 30--39 years (15.8%), whereas the highest rate was in those aged 50--59 years (75.9%). The abdominal surgical approach was used in 84% of all hysterectomies. Surgeries using the vaginal approach required a significantly shorter operating time (118 min average) than all other approaches (P<0.05). Both the amount of bleeding and the blood transfusion volume required were smaller in vaginal approaches, with no significant differences between the others. The surgical approaches used were also related to the scope of surgery. Both the surgical indications and the rates of bilateral oophorectomy varied by age. In terms of both operating time and the amount of bleeding and blood transfusion volume required, the vaginal approach was superior to all other surgical approaches.

Keywords hysterectomy      surgical indications      surgical approach      bilateral oophorectomy     
Corresponding Author(s): Shixuan Wang   
Online First Date: 26 June 2014    Issue Date: 18 December 2014
 Cite this article:   
Jingjing Jiang,Ting Ding,Aiyue Luo, et al. Comparison of surgical indications for hysterectomy by age and approach in 4653 Chinese women[J]. Front. Med., 2014, 8(4): 464-470.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-014-0338-y
https://academic.hep.com.cn/fmd/EN/Y2014/V8/I4/464
Characteristics Age (year)
Total <20 20–29 30–39 40–49 50–59 60-69 70+
Number, N (%) 4653 20 (0.4) 110 (2.4) 895 (19.2) 2299 (49.4) 926 (19.9) 263 (5.7) 140 (3.0)
Menstrual history*
Menarche#, year 14.1 (1.8) 12.9 (1.3)a 13.6 (1.1)b 13.6 (1.5)b 14.0 (1.8)c 14.6 (2.0)d 14.7 (2.2)d 14.6 (2.0)d
Cycle#, d 29.2 (4.9) 29.9 (5.0) b 29.6 (3.2) b 29.4 (4.9) b 28.7 (4.3)a 29.8 (6.0) b 30.2 (4.9) b 30.0 (6.5) b
Duration, d 5.3 (1.9) 4.8 (2.0) 5.2 (1.3) 5.4 (1.8) 5.3 (1.9) 5.1 (2.0) 5.1 (1.7) 4.9 (1.7)
Pregnancy history/Birth **
Gravidity, n 3 0 1 3 3 3 4 5
Parity, n 1 0 1 1 1 2 3 4
Oophorectomy#, n (%) 1626 (35.0) 14 (70.0)c 43 (39.1)b 141 (15.8)a 464 (20.2)a 703 (75.9)c 190 (72.2)c 71 (50.7)b
Tab.1  The baseline characteristics of patients undergoing hysterectomy, stratified by age group
Initial reasons Age (year)
Total <20 20–29 30–39 40–49 50–59 60–69 70+
Abdominal pain, N (%) 1234 (22.5) 11 (39.3) 33 (27.3) 258 (24.4) 662 (24.4) 197 (17.9) 49 (16.2) 24 (14.8)
Colporrhagia, N (%) 1977 (36.1) 1 (3.6) 33 (27.3) 408 (38.5) 995 (36.7) 437 (39.8) 77 (25.5) 26 (16.1)
Abdominal mass, N (%) 985 (18.0) 11 (39.3) 30 (24.8) 135 (12.8) 494 (18.2) 214 (19.5) 66 (21.9) 35 (21.6)
Uterine prolapse, N (%) 219 (4.0) 0 (0) 3 (2.5) 10 (0.9) 41 (1.5) 39 (3.5) 67 (22.2) 59 (36.4)
Abnormal secretion, N (%) 406 (7.4) 0 (0) 7 (5.8) 126 (11.9) 173 (6.4) 78 (7.1) 16 (5.3) 6 (3.7)
Others, N (%) 659 (12.0) 5 (17.9) 15 (12.4) 122 (11.5) 344 (12.7) 134 (12.2) 27 (8.9) 12 (7.4)
Total, N (%) 5480 (100) 28 (100) 121 (100) 1059 (100) 2709 (100) 1099 (100) 320 (100) 162 (100)
Tab.2  The indications for inpatient treatment for hysterectomy in each age group
Age (year)
Total <20 20–29 30–39 40–49 50–59 60–69 70+
Number, N 5729 20 123 1046 2969 1119 287 147
The first four final diagnoses,N (%) UM 2022 (35.3) MOT 12 (60.0) MUT 37 (30.1) MUT 347 (32.6) UM 1303 (43.9) UM 407 (36.4) UP 69 (24) UP 62 (42.2)
MUT 1157 (20.2) CD 3 (15.0) MOT 34 (27.6) UM 237 (22.3) AD 516 (17.4) MUT 243 (21.7) MUT 54 (18.8) UM 20 (13.6)
AD 837 (14.6) BOT 2 (10.0) OF 13 (10.6) AD 176 (16.5) MUT 460 (15.5) MOT 141 (12.6) MOT 53 (18.5) BOT 20 (13.6)
MOT 471 (8.2) MUT 1 (5.0) AD 8 (6.5) MOT 85 (8) EM 219 (7.4) AD 119 (10.6) UM 49 (17.1) MOT 16 (10.9)
ME, N (%) 1628 (28.4) 15 (75.0) * 71 (57.7) 432 (40.6) 590 (19.9) 384 (34.3) 107 (37.3) 31 (21.1)
Tab.3  The first four final diagnoses and malignant etiology of hysterectomy by age
Fig.1  Hospital stay (A) and operating time (B) for the four surgical approaches for hysterectomy. An asterisk indicated significant difference between the marked group and the others, P<0.05. Boxplot of blood loss (C) and blood transfusion volume (D) for four surgical approaches to hysterectomy. (E) The percentage of different scope of surgeries according to surgical approach. Sub-H: subtotal hysterectomy; H: hysterectomy; H+ SO: hysterectomy with unilateral oophorectomy; H+ BO: hysterectomy with bilateral oophorectomy.
1 Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM, Marchbanks PA. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol2008; 198: 34.e1-e7
2 Clarke-Pearson DL, Geller EJ. Complications of hysterectomy. Obstet Gynecol2013; 121(3): 654-673
https://doi.org/10.1097/AOG.0b013e3182841594 pmid: 23635631
3 Schaffer JI, Word A. Hysterectomy—still a useful operation. N Engl J Med2002; 347(17): 1360-1362
https://doi.org/10.1056/NEJMe020109 pmid: 12397196
4 Kuppermann M, Learman LA, Schembri M, Gregorich SE, Jackson RA, Jacoby A, Lewis J, Washington AE. Contributions of hysterectomy and uterus-preserving surgery to health-related quality of life. Obstet Gynecol2013; 122(1): 15-25
pmid: 23787923
5 Nieboer TE, Johnson N, Lethaby A, Tavender E, Curr E, Garry R, van Voorst S, Mol BW, Kluivers KB. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev2009; (3): CD003677
pmid: 19588344
6 Baskett TF. Hysterectomy: evolution and trends. Best Pract Res Clin Obstet Gynaecol2005; 19(3): 295-305
https://doi.org/10.1016/j.bpobgyn.2004.11.007 pmid: 15985249
7 Shifren JL, Avis NE. Surgical menopause: effects on psychological well-being and sexuality. Menopause2007; 14(3 Pt 2 Suppl. 1): 586-591
https://doi.org/10.1097/gme.0b013e318032c505 pmid: 17476149
8 Lieng M, Lomo AB, Qvigstad E. Long-term outcomes following laparoscopic and abdominal supracervical hysterectomies. Obstet Gynecol Int 2010; 2010: 989127
9 ACOG Committee Opinion No. 444: choosing the route of hysterectomy for benign disease. Obstet Gynecol2009; 114(5): 1156-1158
https://doi.org/10.1097/AOG.0b013e3181c33c72 pmid: 20168127
10 Liu H, Lu D, Wang L, Shi G, Song H, Clarke J. Robotic surgery for benign gynaecological disease. Cochrane Database Syst Rev2012; 2: CD008978
pmid: 22336855
11 O’Neill M, Moran PS, Teljeur C, O’Sullivan OE, O’Reilly BA, Hewitt M, Flattery M, Ryan M. Robot-assisted hysterectomy compared to open and laparoscopic approaches: systematic review and meta-analysis. Arch Gynecol Obstet2013; 287(5): 907-918
https://doi.org/10.1007/s00404-012-2681-z pmid: 23291924
12 Wright JD, Ananth CV, Lewin SN, Burke WM, Lu YS, Neugut AI, Herzog TJ, Hershman DL. Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA2013; 309(7): 689-698
https://doi.org/10.1001/jama.2013.186 pmid: 23423414
13 Parker WH. Ovarian conservation versus bilateral oophorectomy at the time of hysterectomy for benign disease. Menopause2014; 21(2): 192-194
pmid: 23880797
14 Borghese B, Chapron C. Treatment of symptomatic uterine fibroids. N Engl J Med2007; 356(21): 2218-2219, author reply 2219
https://doi.org/10.1056/NEJMc070446 pmid: 17526093
15 Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med1993; 328(12): 856-860
https://doi.org/10.1056/NEJM199303253281207 pmid: 8357364
16 Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit2008; 14(1): CR24-CR31
pmid: 18160941
17 Johnson N, Barlow D, Lethaby A, Tavender E, Curr L, Garry R. Methods of hysterectomy: systematic review and meta-analysis of randomised controlled trials. BMJ2005; 330(7506): 1478
https://doi.org/10.1136/bmj.330.7506.1478 pmid: 15976422
18 Hanwright PJ, Mioton LM, Thomassee MS, Bilimoria KY, Van Arsdale J, Brill E, Kim JY. Risk profiles and outcomes of total laparoscopic hysterectomy compared with laparoscopically assisted vaginal hysterectomy. Obstet Gynecol2013; 121(4): 781-787
https://doi.org/10.1097/AOG.0b013e3182887f4e pmid: 23635678
19 Hickey M, Ambekar M, Hammond I. Should the ovaries be removed or retained at the time of hysterectomy for benign disease? Hum Reprod Update2010; 16(2): 131-141
https://doi.org/10.1093/humupd/dmp037 pmid: 19793841
20 Perera HK, Ananth CV, Richards CA, Neugut AI, Lewin SN, Lu YS, Herzog TJ, Hershman DL, Wright JD. Variation in ovarian conservation in women undergoing hysterectomy for benign indications. Obstet Gynecol2013; 121(4): 717-726
https://doi.org/10.1097/AOG.0b013e3182887a47 pmid: 23635670
21 Korbly NB, Kassis NC, Good MM, Richardson ML, Book NM, Yip S, Saguan D, Gross C, Evans J, Lopes VV, Harvie HS, Sung VW. Patient preferences for uterine preservation and hysterectomy in women with pelvic organ prolapse. Am J Obstet Gynecol2013; 209: 470.e1-e6
22 Shuster LT, Gostout BS, Grossardt BR, Rocca WA. Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int2008; 14(3): 111-116
https://doi.org/10.1258/mi.2008.008016 pmid: 18714076
23 ?zdemir S, Celik C, G?rkemli H, Kiyici A, Kaya B. Compared effects of surgical and natural menopause on climacteric symptoms, osteoporosis, and metabolic syndrome. Int J Gynaecol Obstet2009; 106(1): 57-61
https://doi.org/10.1016/j.ijgo.2009.03.016 pmid: 19394614
24 Henderson VW, Sherwin BB. Surgical versus natural menopause: cognitive issues. Menopause2007; 14(3 Pt 2 Suppl. 1): 572-579
https://doi.org/10.1097/gme.0b013e31803df49c pmid: 17476147
25 Jacoby VL, Vittinghoff E, Nakagawa S, Jackson R, Richter HE, Chan J, Kuppermann M. Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions. Obstet Gynecol2009; 113(6): 1259-1267
https://doi.org/10.1097/AOG.0b013e3181a66c42 pmid: 19461420
[1] Yuya Dou, Xiaodan Zhang, Yang Li, Fenfen Wang, Xing Xie, Xinyu Wang. Triage for management of cervical high-grade squamous intraepithelial lesion patients with positive margin by conization: a retrospective analysis[J]. Front. Med., 2017, 11(2): 223-228.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed